S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Urgent Warning (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Urgent Warning (Ad)
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Urgent Warning (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Urgent Warning (Ad)
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Urgent Warning (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Urgent Warning (Ad)
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Small Financial Software Makers Showing Strong Chart Action
Roku And The 20% Rally That’s About To Start 
Urgent Warning (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Don't Be Fooled by These 3 Value Traps
Urgent Warning (Ad)
The Bottom Is In For McCormick & Company
Interactive Brokers: A Better Bet Than Schwab Post-SVB?
NYSE:LEA

Lear - LEA Insider Trading & Ownership

$136.64
-0.31 (-0.23%)
(As of 03/28/2023 12:00 AM ET)
Add
Compare
Today's Range
$136.26
▼
$138.74
50-Day Range
$131.92
▼
$149.46
52-Week Range
$114.67
▼
$158.44
Volume
557,480 shs
Average Volume
598,069 shs
Market Capitalization
$8.08 billion
P/E Ratio
24.98
Dividend Yield
2.25%
Price Target
$155.54

Lear (NYSE:LEA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.67%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$15.03 M

LEA Insider Buying and Selling by Quarter

Get LEA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lear stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Lear Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/9/2023Raymond E ScottCEOSell11,260$138.50$1,559,510.0016,740  
3/3/2023Carl A EspositoSVPSell8,000$142.00$1,136,000.0019,415  
2/23/2023Alicia J DavisSVPSell1,390$144.62$201,021.803,341  
2/14/2023Marianne VidershainVPSell267$141.44$37,764.48272  
2/10/2023Raymond E ScottCEOSell11,261$137.39$1,547,148.7928,000  
12/15/2022Raymond E ScottCEOSell6,142$127.59$783,657.7816,740  
12/2/2022Raymond E ScottCEOSell500$138.45$69,225.0022,882  
11/15/2022Raymond E ScottCEOSell6,143$149.43$917,948.4923,382  
11/15/2022Thomas A. DidonatoSVPSell1,384$149.62$207,074.08  
11/14/2022Frank C OrsiniEVPSell19,501$150.13$2,927,685.1311,842  
11/10/2022Jason M CardewCFOSell1,000$143.66$143,660.009,721  
11/3/2022Thomas A. DidonatoSVPSell1,300$129.03$167,739.00  
10/17/2022Raymond E ScottCEOSell6,143$125.31$769,779.3329,525  
9/15/2022Raymond E ScottCEOSell6,143$136.30$837,290.9035,668  
8/15/2022Raymond E ScottCEOSell6,143$150.51$924,582.9341,811  
7/15/2022Raymond E ScottCEOSell6,143$127.83$785,259.6947,954  
6/27/2022Raymond E ScottCEOSell6,143$134.92$828,813.5654,097  
5/26/2022Alicia J DavisSVPSell2,659$135.14$359,337.261,949  
5/26/2022Conrad L. Mallett, Jr.DirectorSell764$130.74$99,885.36  
5/24/2022Greg C. SmithDirectorSell1,531$129.57$198,371.67  
5/24/2022Raymond E ScottCEOSell4,000$131.38$525,520.0060,240  
(Data available from 1/1/2013 forward)












LEA Insider Trading Activity - Frequently Asked Questions

Who is on Lear's Insider Roster?

The list of insiders at Lear includes Alicia J Davis, Carl A Esposito, Conrad L. Mallett, Jr., Frank C Orsini, Greg C. Smith, Jason M Cardew, Jonathan F Foster, Marianne Vidershain, Raymond E Scott, Thomas A Didonato. Learn more on insiders at LEA.

What percentage of Lear stock is owned by insiders?

0.67% of Lear stock is owned by insiders. Learn more on LEA's insider holdings.

Which Lear insiders have been selling company stock?

The following insiders have sold LEA shares in the last 24 months: Alicia J Davis ($560,359.06), Carl A Esposito ($1,136,000.00), Conrad L. Mallett, Jr. ($99,885.36), Frank C Orsini ($2,927,685.13), Greg C. Smith ($198,371.67), Jason M Cardew ($143,660.00), Jonathan F Foster ($507,114.00), Marianne Vidershain ($68,196.18), Raymond E Scott ($9,548,736.47), and Thomas A. Didonato ($374,813.08).

How much insider selling is happening at Lear?

Insiders have sold a total of 110,687 Lear shares in the last 24 months for a total of $15,564,820.95 sold.

This page (NYSE:LEA) was last updated on 3/29/2023 by MarketBeat.com Staff